Lyme disease (early infection)
Last Updated: 2023-07-07
Author(s): Anzengruber F., Navarini A.
ICD11: 1C1G.0
Last Updated: 2023-07-07
Author(s): Anzengruber F., Navarini A.
ICD11: 1C1G.0
Lyme disease, tick-borne Lyme disease, erythema migrans disease, Lyme borreliosis, Lyme disease, Borrelia burgdorferi infection, European tick-borne Lyme disease.
Early phase of Lyme borreliosis.
3 stages
Plasma cell-rich, perivascular infiltrates are typical.
Therapy according to Lebwohl | Evidence level |
Early stage | |
Doxycycline p.o. 100 mg 2x tgl. for 14 days | A |
Amoxicillin p.o. 500 mg 3x tgl. for 14 days | A |
Cefuroxime p.o. 500 mg 2x tgl. for 14 days | A |
In case of neurological symptoms | |
Cefuroxime i.v. 2g tgl. for 14 days | B |
Penicillin G i.v. 18-24 million IU tgl. (in 4 ED) for 14 days | B |
In case of cardiological symptoms | |
Both oral and intravenous therapy (see.o. possible) | C |
Lyme arthritis without neurological involvement | Doxycylcline p.o. 100 mg 2x tgl. for 14 days |
Amoxicillin 500 mg 3x tgl. for 14 days | |
Lyme arthritis with neurological symptoms | |
Ceftriaxone 2 g i.v. tgl. for 2-3 weeks | B |
Penicillin G 18-24 mIU i.v. (in 4 ED) for 2-3 weeks | |
Chron.-.Recurrent arthritides | |
Recurrent antibiotic therapy for 28 days | D |
Late manifestation of neurological symptoms | |
Ceftriaxone 2 g i.v. tgl. for 2-3 weeks | B |
Penicillin G 18-24 million IU i.v. (in 4 ED) for 2-3 weeks | B |
We Value Your Privacy!
We and our partners are using technologies like cookies and process personal data like the IP-address or browser information in order to personalize the advertising that you see. This helps us to show you more relevant ads and improves your internet experience. We also use it in order to measure results or align our website content. Because we value your privacy, we are herewith asking for your permission to use these technologies. You can always change/withdraw your consent later.